Norden Group LLC Acquires New Position in Encompass Health Corporation $EHC

Key Points

• Norden Group LLC acquired a new position in Encompass Health Corporation, purchasing 6,212 shares valued at approximately $762,000 in the 2nd quarter.
• Encompass Health recently increased its quarterly dividend to $0.19 per share, up from $0.17, with a 0.6% yield and a payout ratio of 13.31%.
• The company reported a 12% year-over-year increase in revenue, reaching $1.46 billion, and an EPS of $1.40, beating estimates by $0.20.

Norden Group LLC bought a new position in Encompass Health Corporation (NYSE:EHC - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 6,212 shares of the company's stock, valued at approximately $762,000.

A number of other institutional investors have also recently made changes to their positions in the company. WPG Advisers LLC purchased a new position in Encompass Health in the 1st quarter worth approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in Encompass Health by 749.0% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company's stock worth $42,000 after buying an additional 367 shares in the last quarter. Arlington Trust Co LLC raised its position in Encompass Health by 22.9% in the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock worth $68,000 after buying an additional 125 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in Encompass Health by 19.0% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock valued at $73,000 after acquiring an additional 115 shares during the period. Finally, SVB Wealth LLC bought a new stake in shares of Encompass Health in the first quarter worth approximately $84,000. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $125.51 on Friday. The company has a market capitalization of $12.64 billion, a P/E ratio of 24.56, a P/E/G ratio of 2.20 and a beta of 0.92. Encompass Health Corporation has a 1-year low of $87.85 and a 1-year high of $127.86. The firm's 50 day simple moving average is $119.27 and its two-hundred day simple moving average is $114.34. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.20 by $0.20. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The company's revenue was up 12.0% on a year-over-year basis. During the same period last year, the firm earned $1.11 EPS. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Research analysts expect that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a dividend of $0.19 per share. This is a boost from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $0.76 annualized dividend and a yield of 0.6%. Encompass Health's dividend payout ratio is 13.31%.

Insider Buying and Selling

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the company's stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the transaction, the executive vice president directly owned 18,846 shares in the company, valued at $2,329,177.14. This represents a 5.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 2.00% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Stephens upgraded shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price on the stock in a report on Thursday, June 5th. KeyCorp lifted their price objective on Encompass Health from $135.00 to $140.00 and gave the stock an "overweight" rating in a report on Tuesday, September 16th. Truist Financial boosted their price target on Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a research note on Thursday, August 14th. Wall Street Zen cut shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. Finally, Bank of America boosted their target price on shares of Encompass Health from $145.00 to $160.00 and gave the company a "buy" rating in a research report on Wednesday, September 10th. One analyst has rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $138.43.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.